MiMedx Group, Inc.
MDXG
$6.68
$0.050.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.53% | -3.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.53% | -3.61% | |||
| Cost of Revenue | 10.36% | 3.14% | |||
| Gross Profit | 10.57% | -5.00% | |||
| SG&A Expenses | 12.78% | 18.52% | |||
| Depreciation & Amortization | 0.52% | 1.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.62% | 13.87% | |||
| Operating Income | -2.72% | -51.13% | |||
| Income Before Tax | -1.49% | -50.81% | |||
| Income Tax Expenses | 7.62% | -36.71% | |||
| Earnings from Continuing Operations | -5.59% | -55.29% | |||
| Earnings from Discontinued Operations | -100.00% | 5,325.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.12% | -54.07% | |||
| EBIT | -2.72% | -51.13% | |||
| EBITDA | 12.07% | -48.67% | |||
| EPS Basic | -8.17% | -53.93% | |||
| Normalized Basic EPS | -3.21% | -49.44% | |||
| EPS Diluted | -2.72% | -56.94% | |||
| Normalized Diluted EPS | -3.85% | -49.28% | |||
| Average Basic Shares Outstanding | 0.03% | -0.25% | |||
| Average Diluted Shares Outstanding | 0.59% | -0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||